Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Stanford University
ViroMissile, Inc.
Bayer
Tizona Therapeutics, Inc
MacroGenics
City of Hope Medical Center
Novartis
University of Southern California
Innate Pharma
Novartis
OncoNano Medicine, Inc.
Compass Therapeutics
NeoTX Therapeutics Ltd.
Abramson Cancer Center at Penn Medicine
Bolt Biotherapeutics, Inc.
AstraZeneca
Actym Therapeutics, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Valo Therapeutics Oy
Memgen, Inc.
University of Virginia
Genentech, Inc.
Eli Lilly and Company
Novartis
Shandong Boan Biotechnology Co., Ltd
Theratechnologies
Tvardi Therapeutics, Incorporated
Turnstone Biologics, Corp.
Seagen Inc.
Sotio Biotech Inc.
Eli Lilly and Company
AstraZeneca
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
NantBioScience, Inc.
Xencor, Inc.
Pfizer
ADC Therapeutics S.A.
Pliant Therapeutics, Inc.
DNAtrix, Inc.
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
Eisai Inc.
National Cancer Institute (NCI)
BioEclipse Therapeutics
Hefei TG ImmunoPharma Co., Ltd.
Fate Therapeutics